The company will do a deal if they can get one at reasonable terms, otherwise they will keep self-funding.
There are many biotech companies doping favorable deals with big pharma after phase 2. If IPIX fails to do a deal in the next few months, it will be a massive blow to the credibility of Leo. This will prove that Leo is the root of all evils at IPIX.
Keeping on self-funding should not be an option because it will be disastrous for shareholder value.